|4Feb 10, 3:58 PM ET

Brown William M 4

4 · 3M CO · Filed Feb 10, 2026

Research Summary

AI-generated summary of this filing

Updated

3M CEO William M Brown Receives Award of 188,055 Shares

What Happened
William M. Brown, Chairman & CEO of 3M Co. (MMM), was granted a derivative equity award covering 188,055 shares on Feb 6, 2026. The Form 4 reports the acquisition at $0.00 (an awarded stock‑option grant), so no cash was exchanged in this transaction. The award will vest and become exercisable in three equal installments on each of the first, second and third anniversaries of the grant date.

Key Details

  • Transaction date: 2026-02-06; Form filed: 2026-02-10 (filed within the 2-business‑day deadline).
  • Transaction type: Award/Grant (derivative) — 188,055 shares; reported acquisition price $0.00.
  • Vesting: Three equal installments on each of the 1st, 2nd and 3rd anniversaries of the grant (per footnote F1).
  • Shares owned after transaction: Not specified in this filing.
  • No indication in the Form that shares were immediately sold or that this was a cashless exercise.

Context
This filing documents a typical executive equity grant (stock options) intended to align long‑term incentives; such awards are routine for executives and do not necessarily reflect immediate buying or selling sentiment. Because the award vests over time, its economic benefit depends on future service and stock performance.

Insider Transaction Report

Form 4
Period: 2026-02-06
Brown William M
Chairman & CEO
Transactions
  • Award

    Non-qualified Stock Option (Right to Buy)

    [F1]
    2026-02-06+188,055188,055 total
    Exercise: $172.65From: 2027-02-06Exp: 2036-02-05Common Stock (188,055 underlying)
Footnotes (1)
  • [F1]The stock option will vest and become exercisable in a series of three equal installments on each of the first, second and third anniversary of the grant date.
Signature
Patricia L. Meagher, attorney-in-fact for William M. Brown|2026-02-10

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT